| Ytd | -68.84% | |
| 1y | -72.00% |
| Open | 2.06 | Prev Close | 2.04 | Low | 2.06 | High | 2.18 | Mkt Cap | 8.23M |
| Vol | 114.95K | Avg Vol | 5.48M | EPS | -24.16 | P/E | -0.09 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.90 | 200-d Avg | 4.12 | 1yr Est | 0.00 |
RGNT News
The approval comes as Regentis prepares for the commercial launch of GelrinC® in Europe, enabling th
European Notified Body approves next-generation manufacturing process that increases production 5-fo
Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular sess
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expe
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
Shares of Sterling Infrastructure Inc (NASDAQ: STRL) jumped 22.5% in pre-market trading after report